✦ LIBER ✦

Peripheral blood monitoring of chronic myeloid leukemia during treatment with imatinib, second-line agents, and beyond

✍ Scribed by Lisa Lima; Leon Bernal-Mizrachi; Debra Saxe; Karen P. Mann; Mourad Tighiouart; Martha Arellano; Leonard Heffner; Morgan McLemore; Amelia Langston; Elliott Winton; Hanna Jean Khoury

Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 273 KB
Volume: 117
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.25678

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Monosomy 7 with severe myelodysplasia de

Monosomy 7 with severe myelodysplasia developing during imatinib treatment of Philadelphia-positive chronic myeloid leukemia: Two cases with a different outcome

✍ José-Tomás Navarro; Evarist Feliu; Javier Grau; Blanca Espinet; Dolors Colomer; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB

Fluorescence in situ hybridization (FISH

Fluorescence in situ hybridization (FISH) on peripheral blood smears for monitoring Philadelphia chromosome-positive chronic myeloid leukemia (CML) during interferon treatment: A new strategy for remission assessment

✍ Josef Mühlmann; Josef Thaler; Wolfgang Hilbe; Oliver Bechter; Martin Erdel; Gerd 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 417 KB 👁 1 views

Interferon-␣ (IFN-␣) alone or in combination with cytostatic drugs can induce major and durable cytogenetic responses in about 20 to 25% of chronic myeloid leukemia (CML) patients. Since these patients have a significant survival benefit, more frequent follow-up investigations have become clinically

Imatinib as the first-line treatment of

Imatinib as the first-line treatment of patients with chronic myeloid leukemia diagnosed in the chronic phase: Can we compare real life data to the results from clinical trials?

✍ Daniela Zackova; Hana Klamova; Ladislav Dusek; Jan Muzik; Katerina Machova Polak 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 286 KB 👁 3 views